A detailed history of Global Trust Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 4,475 shares of ABBV stock, worth $810,601. This represents 0.33% of its overall portfolio holdings.

Number of Shares
4,475
Previous 4,267 4.87%
Holding current value
$810,601
Previous $731,000 20.79%
% of portfolio
0.33%
Previous 0.3%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $34,078 - $41,460
208 Added 4.87%
4,475 $883,000
Q2 2024

Jul 11, 2024

SELL
$154.79 - $180.76 $3,714 - $4,338
-24 Reduced 0.56%
4,267 $731,000
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $1,376 - $1,549
10 Added 0.23%
4,291 $664,000
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $1,870 - $2,165
14 Added 0.33%
4,281 $638,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $13,251 - $16,490
-100 Reduced 2.29%
4,267 $574,000
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $28,922 - $33,308
200 Added 4.8%
4,367 $695,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $67,771 - $81,276
490 Added 13.33%
4,167 $673,000
Q3 2022

Oct 07, 2022

SELL
$134.21 - $153.93 $39,726 - $45,563
-296 Reduced 7.45%
3,677 $493,000
Q2 2022

Jul 12, 2022

SELL
$137.62 - $174.96 $277,992 - $353,419
-2,020 Reduced 33.71%
3,973 $609,000
Q1 2022

Apr 12, 2022

BUY
$131.98 - $163.75 $301,178 - $373,677
2,282 Added 61.49%
5,993 $972,000
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $253,319 - $320,522
2,358 Added 174.28%
3,711 $502,000
Q3 2021

Oct 07, 2021

BUY
$106.4 - $120.78 $319 - $362
3 Added 0.22%
1,353 $146,000
Q2 2021

Jul 13, 2021

BUY
$105.21 - $117.21 $315 - $351
3 Added 0.22%
1,350 $152,000
Q1 2021

Apr 14, 2021

SELL
$102.3 - $112.62 $4,705 - $5,180
-46 Reduced 3.3%
1,347 $146,000
Q4 2020

Jan 13, 2021

SELL
$80.49 - $108.67 $931,913 - $1.26 Million
-11,578 Reduced 89.26%
1,393 $149,000
Q3 2020

Nov 17, 2020

SELL
$85.91 - $100.83 $720,784 - $845,963
-8,390 Reduced 39.28%
12,971 $1.13 Million
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $660,330 - $883,620
9,000 Added 72.81%
21,361 $2.1 Million
Q1 2020

Apr 06, 2020

SELL
$64.5 - $97.79 $1,935 - $2,933
-30 Reduced 0.24%
12,361 $930,000
Q3 2019

Oct 15, 2019

SELL
$62.98 - $75.72 $1.18 Million - $1.42 Million
-18,744 Reduced 60.2%
12,391 $938,000
Q2 2019

Jul 23, 2019

BUY
$65.7 - $83.98 $1.18 Million - $1.51 Million
18,019 Added 137.38%
31,135 $956,000
Q1 2019

Apr 05, 2019

SELL
$77.14 - $90.79 $3,085 - $3,631
-40 Reduced 0.3%
13,116 $1.06 Million
Q4 2018

Jan 11, 2019

SELL
$77.85 - $96.01 $35,032 - $43,204
-450 Reduced 3.31%
13,156 $1.21 Million
Q3 2018

Oct 16, 2018

SELL
$88.91 - $98.84 $1,778 - $1,976
-20 Reduced 0.15%
13,606 $1.29 Million
Q2 2018

Jul 18, 2018

SELL
$89.78 - $106.23 $269,160 - $318,477
-2,998 Reduced 18.03%
13,626 $1.26 Million
Q1 2018

Apr 26, 2018

SELL
$92.01 - $123.21 $281,274 - $376,652
-3,057 Reduced 15.53%
16,624 $1.57 Million
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $1.76 Million - $1.93 Million
19,681
19,681 $1.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Global Trust Asset Management, LLC Portfolio

Follow Global Trust Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.